Avandia safety concerns

FDA is aware of a potential safety issue related to Avandia (rosiglitazone), Concerns are being raised about a possible increased chance of heart attack and One of the safety concerns identified before approval was fluid retention. Moreover the combination of rosiglitazone with insulin resulted in a higher rate of

3 Jun 2013 The positive safety review from Duke University researchers is the latest 2007 analysis that first raised public safety concerns about Avandia

26 Nov 2013 Rosiglitazone is currently taken by only a few thousand patients in safety concerns relating to rosiglitazone for years and are unlikely to be 6 Jun 2013 Avandia, once the most-used diabetes pill on the planet, was all but finished. After concerns emerged that it might cause heart attacks, the Food 24 Sep 2010 New restrictions on the diabetes medication rosiglitazone will require additional steps for physicians who continue to prescribe the drug, which

New Safety Information on Diabetes Drug Rosiglitazone

25 Nov 2013 FDA affirms safety of diabetes drug Avandia, lifts restrictions on use Given these new results, our level of concern is considerably reduced. 13 Jun 2013 FDA Panel Votes in Favor of Loosening Avandia Restrictions As concerns over Avandia39s safety grew among doctors and patients, the FDA

Avandia and Actos have been linked to serious risks, including the Food and Drug Administration39s (FDA39s) primary concern an increased risk of heart attack 17 Jul 2013 News from JAMA Panel Recommends Easing Restrictions on Rosiglitazone Despite Concerns About Cardiovascular Safety